JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $976,000 | -35.0% | 21,358 | -36.2% | 0.00% | -50.0% |
| Q3 2017 | $1,502,000 | -50.6% | 33,480 | -67.1% | 0.00% | -50.0% |
| Q2 2017 | $3,043,000 | -19.1% | 101,798 | -49.0% | 0.00% | -20.0% |
| Q4 2016 | $3,760,000 | -66.8% | 199,463 | -47.2% | 0.01% | -70.6% |
| Q3 2016 | $11,337,000 | +26.9% | 377,787 | +62.5% | 0.02% | +6.2% |
| Q2 2016 | $8,935,000 | +604.7% | 232,432 | +598.3% | 0.02% | +700.0% |
| Q1 2016 | $1,268,000 | +230.2% | 33,285 | +362.3% | 0.00% | +100.0% |
| Q2 2015 | $384,000 | – | 7,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Biomark Capital Management Co. LLC | 1,864,174 | $83,627,000 | 94.97% |
| Crestline Management, LP | 9,348,799 | $419,387,000 | 58.30% |
| Omega Fund Management, LLC | 1,074,612 | $48,207,000 | 27.27% |
| PECONIC PARTNERS LLC | 570,000 | $25,570,000 | 4.12% |
| SIB LLC | 100,000 | $4,486,000 | 3.22% |
| Cormorant Asset Management, LP | 375,000 | $16,823,000 | 2.97% |
| BB BIOTECH AG | 2,055,000 | $92,187,000 | 2.55% |
| Clarius Group, LLC | 117,896 | $5,289,000 | 2.23% |
| Monashee Investment Management LLC | 122,000 | $5,473,000 | 2.07% |
| Iguana Healthcare Management, LLC | 150,000 | $6,730,000 | 1.86% |